Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.

Van Malderen, Carine;Van Geertruyden, Jean-Pierre;Machevo, Sonia;González, Raquel;D' Alessandro, Umberto;et.al.
(2012) Malaria Journal —

Files

boreal_114013.pdf
  • Open Access
  • Adobe PDF
  • 356.44 KB

Details

Authors
  • Van Malderen, CarineUCLouvain
    Author
  • Van Geertruyden, Jean-Pierre
    Author
  • Machevo, Sonia
    Author
  • González, Raquel
    Author
  • Robert, AnnieUCLouvain
    Author
  • D' Alessandro, Umberto
    Author
Show more
Abstract
The use of CDA for treating uncomplicated malaria may increase the risk of haemolytic anaemia in G6PD-deficient children.
Affiliations

Citations

Van Malderen, C., Van Geertruyden, J.-P., Machevo, S., González, R., Bassat, Q., Talisuna, A., Yeka, A., Nabasumba, C., Piola, P., Daniel, A., Turyakira, E., Forret, P., Van Overmeir, C., Van Loen, H., Robert, A., & D’ Alessandro, U. (2012). Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malaria Journal. https://doi.org/10.1186/1475-2875-11-139